Axel Hoos

GlaxoSmithKline (United States) — United States

Medicine · Health Sciences

67h-index41.8kcitations318works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(201), CAR-T cell therapy research(144), Immunotherapy and Immune Responses(78), Immune cells in cancer(34), Melanoma and MAPK Pathways(30)

Publications318 total

Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations
Journal for ImmunoTherapy of Cancer·2024· 5 citedOpen Access
Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science
Cancer Discovery·2023· 14 citedOpen Access
Supplementary Table 3 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Table 6 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Figure 2 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Methods from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Table 4 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Figure 6 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Figure 9 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Figure 12 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Figure 7 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Figure 7 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Movie 1 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
FIGURE 3 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Figure 2 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Movie 1 Legend from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Movie 1 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Table 5 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
Supplementary Table 5 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
FIGURE 4 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
2023Open Access
page 1 of 16Next →

Frequent Co-authors

Jedd D. Wolchok(12), Murray F. Brennan(9), Alexander Stojadinovic(8), F. Stephen Hodi(7), Steven O’Day(7), Jeffrey S. Weber(7), Michele Maio(7), Rachel Humphrey(7), Célèste Lebbé(6), Carlos Cordon‐Cardo(6), Ramy Ibrahim(5), Sylvia Janetzki(5), Caroline Robert(4), James Smothers(4), Denis H. Y. Leung(4), Jonathan J. Lewis(4), Marshall Urist(4), Lloyd J. Old(4), Pramod K. Srivastava(4), Mária Dudás(4)